PCT/1998/43 - World Intellectual Property Organization
PCT/1998/43 - World Intellectual Property Organization
PCT/1998/43 - World Intellectual Property Organization
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>43</strong>/<strong>1998</strong><br />
14942 <strong>PCT</strong> Gazette - Section I - Gazette du <strong>PCT</strong> 29 Oct/oct <strong>1998</strong><br />
(54) • POLYMER–PLATINUM COMPOUNDS<br />
• COMPOSES A BASE DE POLYMERE ET DE<br />
PLATINE<br />
(71) ACCESS PHARMACEUTICALS, INC.<br />
[US/US]; Suite 176, 2600 N. Stemmons Freeway,<br />
Dallas, TX 75207–2107 (US).<br />
(72) DUNCAN, Ruth; Apartment 1<strong>43</strong>B, Chiltern Court,<br />
London NW1 1AX (GB). FERRUTI, Paolo; Via<br />
Plutarco, 13, I–20145 Milano (IT). EVAGOROU,<br />
Evagoras, G.; 112 Park Lane, Tottenham, London<br />
N17 0JP (GB).<br />
(74) MOHR, Judy, M. et al. / etc.; Dehlinger & Associates,<br />
P.O. Box 60850, Palo Alto, CA 9<strong>43</strong>06–0850<br />
(US).<br />
(81) AU CA JP MX TR; EP (AT BE CH CY DE DK<br />
ES FI FR GB GR IE IT LU MC NL PT SE).<br />
(11) WO 98/47497 (13) A2<br />
(21) <strong>PCT</strong>/US98/08164<br />
(22) 23 Apr/avr <strong>1998</strong> (23.04.<strong>1998</strong>)<br />
(25) en (26) en<br />
(31) 08/844,909 (32) 23 Apr/avr 1997<br />
(23.04.1997)<br />
(33) US<br />
(<strong>43</strong>) 29 Oct/oct <strong>1998</strong> (29.10.<strong>1998</strong>)<br />
(51) 6 A61K 31/00<br />
(54) • METHODS AND COMPOSITIONS FOR<br />
THE PREVENTION AND TREATMENT OF<br />
IMMUNOLOGICAL DISORDERS, INFLAM-<br />
MATORY DISEASES AND INFECTIONS<br />
• METHODES ET COMPOSITIONS AFFE-<br />
RENTES AUX FINS DE LA PREVENTION<br />
ET DU TRAITEMENT DE TROUBLES<br />
IMMUNOLOGIQUES, DE MALADIES ET<br />
D’INFECTIONS A CARACTERE INFLAM-<br />
MATOIRE<br />
(63) US 08/844,988 (CON)<br />
23 Apr/avr 1997 (23.04.1997)<br />
(71) FLEMING & COMPANY, PHARMACEUTI-<br />
CALS [US/US]; 1600 Fenpark Drive, Fenton, MO<br />
63026 (US).<br />
(for all designated States except / pour tous les États<br />
désignés sauf US)<br />
(72, 75) FLEMING, Thomas, E. [US/US]; 24 Bopp<br />
Lane, St. Louis, MO 63131 (US). MANSMANN,<br />
Herbert, C., Jr. [US/US]; 1004 Garrett Mill Road,<br />
Newtown Square, PA 19073 (US).<br />
(74) STIEFEL, Maurice, B. et al. / etc.; Bryan Cave<br />
LLP, 245 Park Avenue, New York, NY 10617 (US).<br />
(81) AL AM AT AU AZ BA BB BG BR BY CA CH<br />
CN CU CZ DE DK EE ES FI GB GE GH HU IL<br />
IS JP KE KG KP KR KZ LC LK LR LS LT LU<br />
LV MD MG MK MN MW MX NO NZ PL PT RO<br />
RU SD SE SG SI SK SL TJ TM TR TT UA UG<br />
US UZ VN YU ZW; AP (GH GM KE LS MW SD<br />
SZ UG ZW); EA (AM AZ BY KG KZ MD RU TJ<br />
TM); EP (AT BE CH CY DE DK ES FI FR GB<br />
GR IE IT LU MC NL PT SE); OA (BF BJ CF CG<br />
CI CM GA GN ML MR NE SN TD TG).<br />
(11) WO 98/47498 (13) A1<br />
(21) <strong>PCT</strong>/US98/08182<br />
(22) 23 Apr/avr <strong>1998</strong> (23.04.<strong>1998</strong>)<br />
(25) en (26) en<br />
(31) 60/044,180 (32) 23 Apr/avr 1997<br />
(23.04.1997)<br />
(<strong>43</strong>) 29 Oct/oct <strong>1998</strong> (29.10.<strong>1998</strong>)<br />
(51) 6 A61K 31/16, C07C 235/02<br />
(33) US<br />
(54) • NEUROPROTECTIVE COMPOUNDS AND<br />
USES THEREOF<br />
• COMPOSES NEUROPROTECTEURS ET<br />
LEURS APPLICATIONS<br />
(71) CORNELL RESEARCH FOUNDATION, INC.<br />
[US/US]; Suite 105, 20 Thornwood Drive, Ithaca,<br />
NY 14850 (US). UNIVERSITY OF GEORGIA<br />
RESEARCH FOUNDATION, INC. [US/US];<br />
Boyd Graduate Studies Research Center, Athens,<br />
GA 30601–7411 (US).<br />
(72) JOH, Tong, H.; 315 E. 65th Street, New York, NY<br />
10021 (US). CHO, Sunghee; 555 Central Park<br />
Avenue #125, Scarsdale, NY 10583 (US). CHU,<br />
Chung, K.; 115 Cedar Springs Place, Athens, GA<br />
30605 (US). DU, Jinfa; 115 Cedar Springs Place,<br />
Athens, GA 30605 (US).<br />
(74) GOLDMAN, Michael, L. et al. / etc.; Nixon,<br />
Hargrave, Devans & Doyle LLP, Clinton Square,<br />
P.O. Box 1051, Rochester, NY 14603 (US).<br />
(81) AL AM AT AU AZ BA BB BG BR BY CA CH<br />
CN CU CZ DE DK EE ES FI GB GE GH GM<br />
GW HU ID IL IS JP KE KG KP KR KZ LC LK<br />
LR LS LT LU LV MD MG MK MN MW MX NO<br />
NZ PL PT RO RU SD SE SG SI SK SL TJ TM<br />
TR TT UA UG UZ VN YU ZW; AP (GH GM KE<br />
LS MW SD SZ UG ZW); EA (AM AZ BY KG<br />
KZ MD RU TJ TM); EP (AT BE CH CY DE DK<br />
ES FI FR GB GR IE IT LU MC NL PT SE); OA<br />
(BF BJ CF CG CI CM GA GN ML MR NE SN<br />
TD TG).<br />
(11) WO 98/47499 (13) A1<br />
(21) <strong>PCT</strong>/JP98/01769<br />
(22) 17 Apr/avr <strong>1998</strong> (17.04.<strong>1998</strong>)<br />
(25) en (26) en<br />
(31) 9/117463 (32) 22 Apr/avr 1997<br />
(22.04.1997)<br />
(33) JP<br />
(<strong>43</strong>) 29 Oct/oct <strong>1998</strong> (29.10.<strong>1998</strong>)<br />
(51) 6 A61K 31/165, 9/14, 9/20<br />
(54) • FLUTAMIDE PREPARATIONS AND ME-<br />
THOD FOR MANUFACTURING THE SAME<br />
• PREPARATIONS A BASE DE FLUTAMIDE<br />
ET LEURS PROCEDES DE PREPARATION<br />
(71) NIPPON KAYAKU KABUSHIKI KAISHA<br />
[JP/JP]; 11–2, Fujimi 1–chome, Chiyoda–ku,<br />
Tokyo 102–8172 (JP).<br />
(for all designated States except / pour tous les États<br />
désignés sauf US)<br />
(72, 75) HAMADA, Akinobu [JP/JP]; 6–8–22, Kamiochiai,<br />
Yono–shi, Saitama 338–0001 (JP). YAHIRO,<br />
Tomio [JP/JP]; 6–11–15, Kamiochiai, Yono–shi,<br />
Saitama 338–0001 (JP).<br />
(74) ASAMURA, Kiyoshi et al. / etc.; New Ohtemachi<br />
Building, Room 331, 2–1, Ohtemachi 2–chome,<br />
Chiyoda–ku, Tokyo 100–0004 (JP).<br />
(81) AL AM AU AZ BA BB BG BR BY CA CN CZ<br />
EE GE GW HU ID IL IS KG KR KZ LC LK LR<br />
LT LV MD MG MK MN MX NO NZ PL RO RU<br />
SG SI SK SL TJ TM TR TT UA US UZ VN YU;<br />
AP (GH GM KE LS MW SD SZ UG ZW); EA<br />
(AM AZ BY KG KZ MD RU TJ TM); EP (AT BE<br />
CH CY DE DK ES FI FR GB GR IE IT LU MC<br />
NL PT SE); OA (BF BJ CF CG CI CM GA GN<br />
ML MR NE SN TD TG).<br />
(11) WO 98/47500 (13) A1<br />
(21) <strong>PCT</strong>/US98/06484<br />
(22) 2 Apr/avr <strong>1998</strong> (02.04.<strong>1998</strong>)<br />
(25) en (26) en<br />
(31) 60/044,110 (32) 24 Apr/avr 1997<br />
(24.04.1997)<br />
(33) US<br />
(<strong>43</strong>) 29 Oct/oct <strong>1998</strong> (29.10.<strong>1998</strong>)<br />
(51) 6 A61K 31/165<br />
(54) • USE OF ACETYLDINALINE FOR THE MA-<br />
NUFACTURE OF A MEDICAMENT FOR<br />
THE TREATMENT OF RENAL CELL CAR-<br />
CINOMA<br />
• UTILISATION DE L’ACETYLDINALINE<br />
POUR FABRIQUER UN MEDICAMENT<br />
DESTINE AU TRAITEMENT DU NEPHRO-<br />
CARCINOME<br />
(71) WARNER–LAMBERT COMPANY [US/US];<br />
201 Tabor Road, Morris Plains, NJ 07950 (US).<br />
(for all designated States except / pour tous les États<br />
désignés sauf US)<br />
(72, 75) GROVE, William, Richard [US/US]; 10710<br />
Indianola, Whitmore Lake, MI 48189 (US).<br />
LEOPOLD, Wilbur, Richard [US/US]; 2020 S.<br />
Seventh, Ann Arbor, MI 48103 (US). LORUSSO,<br />
Patricia [US/US]; 23489 Park Lane, Grosse<br />
Ile, MI 48138 (US). MEYER, Mark, Bradley<br />
[US/US]; 1042 S. Higby, Jackson, MI 49203 (US).<br />
(74) RYAN, M., Andrea; Warner–Lambert Company,<br />
201 Tabor Road, Morris Plains, NJ 07950 (US) et<br />
al. / etc.<br />
(81) AL AU BA BB BG BR CA CN CZ EE GE GW<br />
HU ID IL IS JP KR LC LK LR LT LV MG MK<br />
MN MX NO NZ PL RO SG SI SK SL TR TT UA<br />
US UZ VN YU; AP (GH GM KE LS MW SD SZ<br />
UG ZW); EA (AM AZ BY KG KZ MD RU TJ<br />
TM); EP (AT BE CH CY DE DK ES FI FR GB<br />
GR IE IT LU MC NL PT SE); OA (BF BJ CF CG<br />
CI CM GA GN ML MR NE SN TD TG).<br />
(11) WO 98/47501 (13) A1<br />
(21) <strong>PCT</strong>/IB98/00549<br />
(22) 14 Apr/avr <strong>1998</strong> (14.04.<strong>1998</strong>)<br />
(25) en (26) en<br />
(31) RM97A000241 (32) 24 Apr/avr 1997<br />
(24.04.1997)<br />
(33) IT<br />
(<strong>43</strong>) 29 Oct/oct <strong>1998</strong> (29.10.<strong>1998</strong>)<br />
(51) 6 A61K 31/18, 47/10, 7/22<br />
(54) • PHARMACEUTICAL PREPARATION CON-<br />
TAINING NIMESULIDE FOR ORAL ADMI-<br />
NISTRATION<br />
• PREPARATION PHARMACEUTIQUE CON-<br />
TENANT DU NIMESULIDE POUR ADMINIS-<br />
TRATION ORALE<br />
(71) ERREKAPPA EUROTERAPICI S.P.A. [IT/IT];<br />
Via Ciro Menotti, 1/A, I–20129 Milan (IT).<br />
(for all designated States except / pour tous les États<br />
désignés sauf US)<br />
(72, 75) GIORGETTI, Paolo, Luca, Maria [IT/IT];<br />
Via Ciro Menotti, 1/A, I–20129 Milan (IT).<br />
(74) MASPOLI, René, A.; Patentanwaltsbureau<br />
R.A. Maspoli, Witikon–Zentrum, P.O. Box 191,<br />
CH–8053 Zurich (CH).<br />
(81) CA CN JP KR US; EP (AT BE CH CY DE DK ES<br />
FI FR GB GR IE IT LU MC NL PT SE).<br />
(11) WO 98/47502 (13) A1<br />
(21) <strong>PCT</strong>/EP98/02318<br />
(22) 20 Apr/avr <strong>1998</strong> (20.04.<strong>1998</strong>)<br />
(25) de (26) de<br />
(31) 197 16 713.6 (32) 21 Apr/avr 1997<br />
(21.04.1997)<br />
(<strong>43</strong>) 29 Oct/oct <strong>1998</strong> (29.10.<strong>1998</strong>)<br />
(51) 6 A61K 31/19, 31/70<br />
(33) DE